Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1411327Generated: November 2, 2026

5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3'-pyrrolidine]-1-carboxamide → (R)-5-chloro-N1-(5-chlorothiazol-2-yl)-N1'-methylspiro[indoline-3,3'-pyrrolidine]-1,1'-dicarboxamide

https://huagongshe.com/reaction/1411327

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3'-pyrrolidine]-1-carboxamideHCID 90449271—
Reactant(S)-5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3'-pyrrolidine]-1-carboxamideHCID 90449948—
Product(R)-5-chloro-N1-(5-chlorothiazol-2-yl)-N1'-methylspiro[indoline-3,3'-pyrrolidine]-1,1'-dicarboxamideHCID 90449740—

Reaction Steps

The captioned compound was obtained in the form of a white solid by performing the same reactions and/or treatments as those in Example 373, with the exception that the (S)-5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide obtained as an intermediate of Example 52 was used instead of 5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08921576B2
Source datasetuspto-grants-2014_12
ORD IDord-ca58e6f3cf1948009b737b10137bd5f2
Source noteuspto-grants-2014_12